166 related articles for article (PubMed ID: 25202074)
41. Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia.
Haaland I; Opsahl JA; Berven FS; Reikvam H; Fredly HK; Haugse R; Thiede B; McCormack E; Lain S; Bruserud O; Gjertsen BT
Mol Cancer; 2014 May; 13():116. PubMed ID: 24885082
[TBL] [Abstract][Full Text] [Related]
42. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
[TBL] [Abstract][Full Text] [Related]
43. Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
Pelicano H; Carew JS; McQueen TJ; Andreeff M; Plunkett W; Keating MJ; Huang P
Leukemia; 2006 Apr; 20(4):610-9. PubMed ID: 16482209
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
45. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.
Ryhänen T; Mannermaa E; Oksala N; Viiri J; Paimela T; Salminen A; Atalay M; Kaarniranta K
Eur J Pharmacol; 2008 Apr; 584(2-3):229-36. PubMed ID: 18313664
[TBL] [Abstract][Full Text] [Related]
46. Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells.
Boridy S; Le PU; Petrecca K; Maysinger D
Cell Death Dis; 2014 May; 5(5):e1216. PubMed ID: 24810052
[TBL] [Abstract][Full Text] [Related]
47. Phosphorylation of AKT induced by phosphorylated Hsp27 confers the apoptosis-resistance in t-AUCB-treated glioblastoma cells in vitro.
Li R; Li J; Sang D; Lan Q
J Neurooncol; 2015 Jan; 121(1):83-9. PubMed ID: 25200832
[TBL] [Abstract][Full Text] [Related]
48. [Thermosensitization of tumor cells with inhibitors of chaperone activity and expression].
Kudriavtsev VA; Makarova IuM; Kabakav AE
Biomed Khim; 2012; 58(6):662-72. PubMed ID: 23350198
[TBL] [Abstract][Full Text] [Related]
49. The effect of 17-allylamino-17-demethoxygeldanamycin alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2015 Apr; 48(3):886-93. PubMed ID: 25096912
[TBL] [Abstract][Full Text] [Related]
50. Re-examining HSPC1 inhibitors.
Lee SL; Dempsey-Hibbert NC; Vimalachandran D; Wardle TD; Sutton PA; Williams JH
Cell Stress Chaperones; 2017 Mar; 22(2):293-306. PubMed ID: 28255900
[TBL] [Abstract][Full Text] [Related]
51. Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment.
Jakubowicz-Gil J; Langner E; Bądziul D; Wertel I; Rzeski W
Toxicol Appl Pharmacol; 2013 Dec; 273(3):580-9. PubMed ID: 24126416
[TBL] [Abstract][Full Text] [Related]
52. Heat stress pretreatment decreases lipopolysaccharide-induced apoptosis via the p38 signaling pathway in human umbilical vein endothelial cells.
Liu Z; Zhong T; Zheng D; Cepinskas I; Peng T; Su L
Mol Med Rep; 2016 Jul; 14(1):1007-13. PubMed ID: 27222013
[TBL] [Abstract][Full Text] [Related]
53. The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice.
Abu-Elsaad NM; Serrya MS; El-Karef AM; Ibrahim TM
Pharmacol Rep; 2016 Apr; 68(2):275-82. PubMed ID: 26922527
[TBL] [Abstract][Full Text] [Related]
54. Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells.
Önay Uçar E; Şengelen A
Cell Stress Chaperones; 2019 Jul; 24(4):763-775. PubMed ID: 31073903
[TBL] [Abstract][Full Text] [Related]
55. Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90.
Dungey FA; Caldecott KW; Chalmers AJ
Mol Cancer Ther; 2009 Aug; 8(8):2243-54. PubMed ID: 19671736
[TBL] [Abstract][Full Text] [Related]
56. Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF.
Konda JD; Olivero M; Musiani D; Lamba S; Di Renzo MF
Mol Oncol; 2017 Jun; 11(6):599-611. PubMed ID: 28182330
[TBL] [Abstract][Full Text] [Related]
57. The HSP90 inhibitor 17-AAG potentiates the antileishmanial activity of the ether lipid edelfosine.
Varela-M RE; Mollinedo-Gajate C; Muro A; Mollinedo F
Acta Trop; 2014 Mar; 131():32-6. PubMed ID: 24299925
[TBL] [Abstract][Full Text] [Related]
58. The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cells.
Jane EP; Pollack IF
Cancer Lett; 2008 Sep; 268(1):46-55. PubMed ID: 18462865
[TBL] [Abstract][Full Text] [Related]
59. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).
Wang X; Chen M; Zhou J; Zhang X
Int J Oncol; 2014 Jul; 45(1):18-30. PubMed ID: 24789222
[TBL] [Abstract][Full Text] [Related]
60. The role of heat shock protein 90 in the regulation of tumor cell apoptosis.
Kaigorodova EV; Ryazantseva NV; Novitskii VV; Belkina MV; Maroshkina AN
Bull Exp Biol Med; 2011 Feb; 150(4):450-2. PubMed ID: 22268041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
